Treatment Registry of Arrhythmias, Complications and Electrocardiograms in Arrhythmogenic CardioMyopathies
Starting soon
Conditions studied: Arrhythmogenic Cardiomyopathy (AC, ARVD/C), Ventricular Tachycardia (VT), Ventricular Fibrillation, ICD, ICD Malfunction, ICD SHOCKS, Ventricular Arrhythmias and Cardiac Arrest, Ventricular Arrhythmia
In brief
TRACE-ACM is a multicenter, retrospective, observational study of patients with arrhythmogenic cardiomyopathy who received an implantable cardioverter-defibrillator (ICD) and had documented ventricular tachyarrhythmias. The study aims to describe the prevalence and type of ICD-related complications, characterize ventricular arrhythmias documented by ICD electrograms and/or ECG recordings, and explore associations between clinical, device-related, and treatment-related factors and arrhythmic outcomes.
Key facts
- Study ID
- NCT07688200
- Run by
- Policlinico Casilino ASL RMB
- People needed
- 300
- Starts
- 2026-07-01
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2026-07-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of arrhythmogenic cardiomyopathy, including right-dominant arrhythmogenic right ventricular cardiomyopathy, biventricular arrhythmogenic cardiomyopathy, or left-dominant arrhythmogenic left ventricular cardiomyopathy.
- ICD implantation.
- Documented sustained ventricular tachyarrhythmia, including polymorphic ventricular tachycardia, ventricular fibrillation, or monomorphic ventricular tachycardia.
- Periodic clinical and ICD follow-up.
- Arrhythmia onset available from ICD electrograms and/or ECG recordings.
- ECG/EGM tracings available for analysis by the steering ECG committee.
You may not qualify if…
- Incomplete ICD data or incomplete ICD follow-up.
- Significant coronary artery disease, defined as coronary plaque greater than 50% at coronary angiography or coronary computed tomography angiography.
- Primary valvular heart disease or congenital heart disease.
- Infiltrative or inflammatory cardiomyopathies, including sarcoidosis or amyloidosis.
- Previous exposure to therapies associated with cardiac toxicity, including chemotherapy.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.